Detalhe da pesquisa
1.
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action.
Diabetes Obes Metab
; 18 Suppl 2: 3-16, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27723228
2.
A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1.
Diabetes Obes Metab
; 18 Suppl 2: 25-33, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27393697
3.
Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3.
Diabetes Obes Metab
; 18(11): 1081-1088, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27265390
4.
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.
Diabetes Obes Metab
; 18 Suppl 2: 50-58, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27723227
5.
Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial.
Diabetes Obes Metab
; 18(11): 1055-1064, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27349219